SCHEMBL29947451

SCHEMBL29947451

CC(O)c1cncc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
PDE2A O00408 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PNMT P11086 1/20 0.39
GPR55 Q9Y2T6 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
IDH1 O75874 1/20 0.38
AGBL2 Q5U5Z8 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
USP36 Q9P275 1/20 0.35
TRPV3 Q8NET8 1/20 0.34
ACACB O00763 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26981280 1.00 CYP11B1 (0.40) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
SCHEMBL19819840 0.84 PNMT (0.41) CYP11B1CYP11B2SMN1; SMN2PNMTGPR55
SCHEMBL10084726 0.84 GPR55 (0.40) CYP11B1CYP11B2SMN1; SMN2PNMTGPR55
SCHEMBL26743188 0.81 GPR55 (0.38) CYP11B1CYP11B2PDE2ASMN1; SMN2GPR55
SCHEMBL13018923 0.81 GPR55 (0.38) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
SCHEMBL30661349 0.81 PDE2A (0.39) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
SCHEMBL26743151 0.81 PDE2A (0.39) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
Hydrochloric Acid SCHEMBL28929728 0.79 PDE2A (0.38) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
Hydrochloric Acid SCHEMBL28929729 0.79 PDE2A (0.38) CYP11B1CYP11B2PDE2ASMN1; SMN2PNMT
SCHEMBL29010056 0.79 AKR1C3 (0.47) SMN1; SMN2KDM4EALDH1A1AGBL2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079983-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
CN-122079984-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
CN-122079985-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
CN-119421882-A FGFR2 inhibitor compounds 伊莱利利公司 2025-02-11 CN disclosed
EP-4301468-A1 FGFR3 INHIBITOR COMPOUNDS Eli Lilly and Company (US) 2024-01-10 EP disclosed
WO-2022187443-A1 FGFR3 INHIBITOR COMPOUNDS ELI LILLY AND COMPANY (US) 2022-09-09 WO disclosed